Ausgabe 5/2008
Inhalt (15 Artikel)
Clinical impact of HLA class I expression in rectal cancer
Frank M. Speetjens, Elza C. de Bruin, Hans Morreau, Eliane C. M. Zeestraten, Hein Putter, J. Han van Krieken, Maaike M. van Buren, Monique van Velzen, N. Geeske Dekker-Ensink, Cornelis J. H. van de Velde, Peter J. K. Kuppen
An immunotherapy approach with dendritic cells genetically modified to express the tumor-associated antigen, HER2
Tsukasa Nabekura, Toshiro Nagasawa, Hiromitsu Nakauchi, Masafumi Onodera
Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma
Fiona C. Thistlethwaite, Eyad Elkord, Richard W. Griffiths, Deborah J. Burt, Alaaeldin M. Shablak, John D. M. Campbell, David E. Gilham, Eric B. Austin, Peter L. Stern, Robert E. Hawkins
Migration deficit in monocyte-macrophages in human ovarian cancer
Ralph S. Freedman, Qing Ma, Ena Wang, Stacie T. Gallardo, Ilyssa O. Gordon, Jeong Won Shin, Ping Jin, David Stroncek, Francesco M. Marincola
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells
A. Nazmul H. Khan, Christopher J. Gregorie, Thomas B. Tomasi
Ly49G2 receptor blockade reduces tumor burden in a leukemia model but not in a solid tumor model
Melissa A. Barber, Tong Zhang, Bethany A. Gagne, Jo A. Van Ginderachter, Patrick De Baetselier, Charles L. Sentman
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction
Hovav Nechushtan, Dien Pham, Yu Zhang, Daniel Morgensztern, Kyung H. Yi, Seung-Uon Shin, Howard J. Federoff, William J. Bowers, Khaled A. Tolba, Joseph D. Rosenblatt
Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients
Hui Wang, Chuanping Cao, Beilei Li, Shaoliang Chen, Jun Yin, Jing Shi, Dan Ye, Qun Tao, Peisheng Hu, Alan Epstein, Dianwen Ju
Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy
Selma Ugurel, David Schrama, Gunhild Keller, Dirk Schadendorf, Eva-Bettina Bröcker, Roland Houben, Marc Zapatka, Wolfram Fink, Howard L. Kaufman, Jürgen C. Becker
MYCN as a target for cancer immunotherapy
Nourredine Himoudi, Mengyong Yan, Antigoni Papanastasiou, John Anderson
Anti-inflammatory pretreatment enables an efficient dendritic cell-based immunotherapy against established tumors
Paula Chiarella, Marisa Vulcano, Juan Bruzzo, Mónica Vermeulen, Silvia Vanzulli, Andrea Maglioco, Gabriela Camerano, Víctor Palacios, Gabriela Fernández, Romina Fernández Brando, Martín A. Isturiz, Graciela I. Dran, Oscar D. Bustuoabad, Raúl A. Ruggiero
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines
Rosa Méndez, Teresa Rodríguez, Ana Del Campo, Eva Monge, Isabel Maleno, Natalia Aptsiauri, Pilar Jiménez, Susana Pedrinaci, Graham Pawelec, Francisco Ruiz-Cabello, Federico Garrido
Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma
Anna De Geer, Lena-Maria Carlson, Per Kogner, Jelena Levitskaya
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes
Pierre Larrieu, Virginie Renaud, Yann Godet, Francine Jotereau, Jean-François Fonteneau